1.
Hradyk Т, Tsysnetska А. The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients with Type 2 Diabetes Mellitus. APMPLMI [Internet]. 2022 May 13 [cited 2025 Sep. 8];3(1):1-10. Available from: https://apmplmi.com/index.php/apmp/article/view/42